Overview

Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans

Status:
Completed
Trial end date:
2011-07-21
Target enrollment:
Participant gender:
Summary
Placebo-controlled, double-blind, randomized study. Post-infectious bronchiolitis obliterans (PIBO) patients aged 5 years and older of both sexes were enrolled.
Phase:
Phase 4
Details
Lead Sponsor:
Claudio Castanos
Treatments:
Azithromycin